Disappointing to close on the day's low.
Apart from the relationship with the US Advisors, a deal with Adheris hasn't been mentioned in previous announcement, so this comes as a surprise.
What has been published a number of times is PDX going live in April.
The next few months look busy. If they can turn these agreements into just 10% of the annual revenue numbers they're predicting, then H1FY20 looks to be where we see a step change in customer numbers and big pharma programs.
March - Adheris
April/May - PDX Inc
June/July - Zuellig
Ann: MedAdvisor Announces Agreement with Adheris Health SA, page-21
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $220.5M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 41.5¢ | 40.0¢ | $43.65K | 108.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 46211 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 16830 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MDR (ASX) Chart |